Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
50.0%
% of PPH's 25 holdings also in XPH
29.3%
% of XPH's 41 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ZOETIS INC | 5.2% | 4.7% | 4.7% |
|
MERCK & CO. INC. | 5.4% | 4.2% | 4.2% |
|
ELI LILLY & CO | 5.2% | 4.0% | 4.0% |
|
VIATRIS, INC. | 3.8% | 3.8% | 3.8% |
|
JOHNSON & JOHNSON | 7.5% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XPH
 |
NOVO-NORDISK A/S-SPONS ADR | 5.9% |
|
ABBVIE INC | 5.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 5.3% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.0% |
 |
SANOFI-AVENTIS-ADR | 4.7% |
 |
NOVARTIS AG-ADR | 4.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.4% |
|
AMERISOURCEBERGEN CORP | 4.2% |
|
MCKESSON CORP | 4.2% |
|
JOHNSON & JOHNSON | 3.8% |
PPH Underweight Relative to XPH
|
REVANCE THERAPEUTICS INC | -6.0% |
|
REATA PHARMACEUTICALS, INC. CLASS A | -5.5% |
|
AXSOME THERAPEUTICS, INC. | -3.7% |
|
ROYALTY PHARMA PLC CLASS A | -3.6% |
 |
PERRIGO CO | -3.4% |
|
CATALENT INC | -3.4% |
|
INTRA-CELLULAR THERAPIES INC | -3.0% |
|
CASSAVA SCIENCES, INC. | -3.0% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.8% |
|
PROVENTION BIO, INC. | -2.2% |